Literature DB >> 9312069

Inhibition of aminoglycoside antibiotic resistance enzymes by protein kinase inhibitors.

D M Daigle1, G A McKay, G D Wright.   

Abstract

Bacterial resistance to the aminoglycoside antibiotics is manifested primarily through the expression of enzymes which covalently modify these drugs. One important mechanism of aminoglycoside modification is through ATP-dependent O-phosphorylation, catalyzed by a family of aminoglycoside kinases. The structure of one of these kinases, APH(3')-IIIa has recently been determined by x-ray crystallography, and the general fold is strikingly similar to eukaryotic protein kinases (Hon, W. C., McKay, G. A., Thompson, P. R., Sweet, R. M., Yang, D. S. C., Wright, G. D., and Berghuis, A. M. (1997) Cell 89, 887-895). Based on this similarity, we have examined the effect of known inhibitors of eukaryotic protein kinases on two aminoglycoside kinases, APH(3')-IIIa and the enzyme AAC(6')-APH(2") which also exhibits acetyl-CoA-dependent aminoglycoside modification activity. We report that several known protein kinase inhibitors are also good inhibitors of aminoglycoside kinases. Compounds belonging to the isoquinolinesulfonamide group are especially effective in this regard, giving competitive inhibition in the micromolar range with respect to ATP and noncompetitive inhibition versus the aminoglycoside substrate. This study provides the basis for future aminoglycoside kinase inhibitor design and for the development of compounds which could reverse antibiotic resistance in the clinic.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312069     DOI: 10.1074/jbc.272.40.24755

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Aminoglycosides: activity and resistance.

Authors:  M P Mingeot-Leclercq; Y Glupczynski; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

2.  Structural basis for dual nucleotide selectivity of aminoglycoside 2''-phosphotransferase IVa provides insight on determinants of nucleotide specificity of aminoglycoside kinases.

Authors:  Kun Shi; Albert M Berghuis
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

3.  Crystallization and preliminary crystallographic analysis of an aminoglycoside kinase from Legionella pneumophila.

Authors:  Christopher T Lemke; Jiyoung Hwang; Bing Xiong; Nicholas P Cianciotto; Albert M Berghuis
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-06-01

4.  Homologous Recombination in Core Genomes Facilitates Marine Bacterial Adaptation.

Authors:  Ying Sun; Haiwei Luo
Journal:  Appl Environ Microbiol       Date:  2018-05-17       Impact factor: 4.792

5.  Understanding and overcoming aminoglycoside resistance caused by N-6'-acetyltransferase.

Authors:  Kenward Vong; Karine Auclair
Journal:  Medchemcomm       Date:  2012-04-01       Impact factor: 3.597

6.  Antibiotic resistance and inhibition mechanism of novel aminoglycoside phosphotransferase APH(5) from B. subtilis subsp. subtilis strain RK.

Authors:  Rishikesh S Parulekar; Sagar S Barale; Kailas D Sonawane
Journal:  Braz J Microbiol       Date:  2019-08-10       Impact factor: 2.476

7.  Nucleotide selectivity of antibiotic kinases.

Authors:  Tushar Shakya; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

Review 8.  Aminoglycoside modifying enzymes.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Drug Resist Updat       Date:  2010-09-15       Impact factor: 18.500

9.  Structure of the antibiotic resistance factor spectinomycin phosphotransferase from Legionella pneumophila.

Authors:  Desiree H Fong; Christopher T Lemke; Jiyoung Hwang; Bing Xiong; Albert M Berghuis
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

Review 10.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.